92 related articles for article (PubMed ID: 24155157)
1. Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures.
Bhattacharya I; Gotfried MH; Ji AJ; Saunders JP; Gourley I; Diehl A; Korth-Bradley JM
J Clin Pharmacol; 2014 Jan; 54(1):70-4. PubMed ID: 24155157
[TBL] [Abstract][Full Text] [Related]
2. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.
Rodvold KA; Gotfried MH; Cwik M; Korth-Bradley JM; Dukart G; Ellis-Grosse EJ
J Antimicrob Chemother; 2006 Dec; 58(6):1221-9. PubMed ID: 17012300
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
[TBL] [Abstract][Full Text] [Related]
4. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
[TBL] [Abstract][Full Text] [Related]
5. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.
Conte JE; Golden JA; Kelly MG; Zurlinden E
Int J Antimicrob Agents; 2005 Jun; 25(6):523-9. PubMed ID: 15885987
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline pharmacokinetics in subjects with various degrees of renal function.
Korth-Bradley JM; Troy SM; Matschke K; Muralidharan G; Fruncillo RJ; Speth JL; Raible DG
J Clin Pharmacol; 2012 Sep; 52(9):1379-87. PubMed ID: 21953572
[TBL] [Abstract][Full Text] [Related]
7. A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS.
Ji AJ; Saunders JP; Amorusi P; Wadgaonkar ND; O'Leary K; Leal M; Dukart G; Marshall B; Fluhler EN
J Pharm Biomed Anal; 2008 Nov; 48(3):866-75. PubMed ID: 18692977
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetic and pharmacodynamic profile of tigecycline.
Meagher AK; Ambrose PG; Grasela TH; Ellis-Grosse EJ
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S333-40. PubMed ID: 16080071
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of tigecycline in healthy volunteers.
Van Wart SA; Cirincione BB; Ludwig EA; Meagher AK; Korth-Bradley JM; Owen JS
J Clin Pharmacol; 2007 Jun; 47(6):727-37. PubMed ID: 17519399
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.
Muralidharan G; Micalizzi M; Speth J; Raible D; Troy S
Antimicrob Agents Chemother; 2005 Jan; 49(1):220-9. PubMed ID: 15616299
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a potential tigecycline-warfarin drug interaction.
Zimmerman JJ; Raible DG; Harper DM; Matschke K; Speth JL
Pharmacotherapy; 2008 Jul; 28(7):895-905. PubMed ID: 18576904
[TBL] [Abstract][Full Text] [Related]
12. Absence of an interaction between tigecycline and digoxin in healthy men.
Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
[TBL] [Abstract][Full Text] [Related]
13. Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.
Bulik CC; Wiskirchen DE; Shepard A; Sutherland CA; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2010 Dec; 54(12):5209-13. PubMed ID: 20921312
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline does not prolong corrected QT intervals in healthy subjects.
Korth-Bradley JM; McGovern PC; Salageanu J; Matschke K; Plotka A; Pawlak S
Antimicrob Agents Chemother; 2013 Apr; 57(4):1895-901. PubMed ID: 23403419
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis.
Korth-Bradley JM; Baird-Bellaire SJ; Patat AA; Troy SM; Böhmer GM; Gleiter CH; Buecheler R; Morgan MY
J Clin Pharmacol; 2011 Jan; 51(1):93-101. PubMed ID: 20308689
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.
Van Wart SA; Owen JS; Ludwig EA; Meagher AK; Korth-Bradley JM; Cirincione BB
Antimicrob Agents Chemother; 2006 Nov; 50(11):3701-7. PubMed ID: 16940069
[TBL] [Abstract][Full Text] [Related]
17. Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults.
Pai MP
J Antimicrob Chemother; 2014 Jan; 69(1):190-9. PubMed ID: 23883872
[TBL] [Abstract][Full Text] [Related]
18. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.
Ray L; Levasseur K; Nicolau DP; Scheetz MH
Ann Pharmacother; 2010 Mar; 44(3):582-6. PubMed ID: 20179255
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations.
Sun HK; Ong CT; Umer A; Harper D; Troy S; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 2005 Apr; 49(4):1629-32. PubMed ID: 15793157
[TBL] [Abstract][Full Text] [Related]
20. Tigecycline penetration into skin and soft tissue.
Stein GE; Smith CL; Missavage A; Saunders JP; Nicolau DP; Battjes SM; Kepros JP
Surg Infect (Larchmt); 2011 Dec; 12(6):465-7. PubMed ID: 22136488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
